Article
New regulatory thinking is needed for AI-based personalised drug and cell therapies in precision oncology - npj Precision Oncology
Rating:
0.0
Views:
29
Likes:
1
Library:
1
Until recently the application of artificial intelligence (AI) in precision oncology was confined to activities in drug development and had limited impact on the personalisation of therapy. Now, a number of approaches have been proposed for the personalisation of drug and cell therapies with AI applied to therapy design, planning and delivery at the patient's bedside.
Rate This Post
Rate The Educational Value
Rate The Ease of Understanding and Presentation
Interesting or Boring? Rate the Entertainment Value